Revision of Sekar Kathiresan
mediawikibotAB-V1Rendered
Sekar Kathiresan is chief executive officer and co-founder of Verve Therapeutics. Verve is pioneering a new approach to the care of cardiovascular disease by developing single-course gene-editing therapies that safely and durably lower plasma LDL cholesterol in order to treat atherosclerotic cardiovascular disease. from Wikipedia
physician-geneticist and preventive cardiologist
Wikitext diff vs parent
{{DISPLAYTITLE:Sekar Kathiresan}}Sekar Kathiresan, M.D. is a physician-geneticist who is co-founder and chief executive officer of Verve Therapeutics.<small> from [https://en.wikipedia.org/wiki/Sekar_Kathiresan Wikipedia]</small>{||+|-! Icon !! Service !! Username !!Sekar Kathiresan is chief executive officer and co-founder of Verve Therapeutics. Verve is pioneering a new approach to the care of cardiovascular disease by developing single-course gene-editing therapies that safely and durably lower plasma LDL cholesterol in order to treat atherosclerotic cardiovascular disease.<small> from [https://en.wikipedia.org/wiki/Sekar_Kathiresan Wikipedia]</small> {{SF| {{Twt|skathire}}|}}} {{IDF| {{Gog|/g/11g0kd2knj}} }}[[VHID]]:[https://verifiedhandles.com/vhid/26894905656 26894905656]{{#subtitle: <big>physician-geneticist and preventive cardiologist</big>}}{{VHID|26894905656}}{{#subtitle: <big>physician-geneticist and preventive cardiologist</big>}}